InDex Pharmaceuticals will participate in the Digestive Disease Week (DDW)
May 5, 2017 – InDex Pharmaceuticals Holding AB (publ) today announced that the company will present two posters at the Digestive Disease Week (DDW). DDW is the largest congress in the world within gastroenterology. The congress is held in Chicago, US on May 6-9, 2017.Both posters will be presented during the poster session on Monday May 8. The first poster has the title Binding properties of human TLR-9 receptor to cobitolimod – a candidate for treatment of active Ulcerative Colitis in late stage of clinical development, and shows the binding affinity of cobitolimod to the receptor Toll-